Cargando…
The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
Somatic non-synonymous mutations in the DNA of tumor cells may result in the presentation of tumor-specific peptides to T cells. The recognition of these so-called neoepitopes now has been firmly linked to the clinical success of checkpoint blockade and adoptive T cell therapy. Following proof-of-pr...
Autores principales: | Verdegaal, Els M. E., van der Burg, Sjoerd H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604073/ https://www.ncbi.nlm.nih.gov/pubmed/28959257 http://dx.doi.org/10.3389/fimmu.2017.01113 |
Ejemplares similares
-
The neoepitope landscape of breast cancer: implications for immunotherapy
por: Narang, Pooja, et al.
Publicado: (2019) -
The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017) -
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
por: Wickström, Stina L., et al.
Publicado: (2019) -
NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
por: Xia, Jiaqi, et al.
Publicado: (2021) -
Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)